quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:27·969d
INSIDERFiling
Recro Pharma Inc. logo

SEC Form 4: Miller James Charles bought $15,000 worth of shares (37,500 units at $0.40), increasing direct ownership by 20% to 227,543 units

REPH· Recro Pharma Inc.
Health Care
Original source

Companies

  • REPH
    Recro Pharma Inc.
    Health Care

Recent analyst ratings

  • Oct 12UpdateWilliam Blair-

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)
  • INSIDER807d
    Lake Ryan David covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 0.13% to 800,557 units (SEC Form 4)
  • INSIDER818d
    Enloe J David Jr was granted 196,474 shares, increasing direct ownership by 18% to 1,295,414 units (SEC Form 4)
  • INSIDER818d
    Lake Ryan David was granted 110,025 shares and covered exercise/tax liability with 37,453 shares, increasing direct ownership by 10% to 801,579 units (SEC Form 4)
  • INSIDER821d
    Lake Ryan David covered exercise/tax liability with 34,096 shares, decreasing direct ownership by 4% to 729,007 units (SEC Form 4)
  • INSIDER840d
    Lake Ryan David covered exercise/tax liability with 1,419 shares, decreasing direct ownership by 0.19% to 763,103 units (SEC Form 4)
  • INSIDER856d
    Lake Ryan David covered exercise/tax liability with 5,690 shares, decreasing direct ownership by 0.74% to 764,522 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022